| A Novel Computer-Based Functional Skills Assessment and Training Program (NCT04679441) | i-Function, Inc. | 2021-08-01 |
| Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain (NCT05050448) | ZetrOZ, Inc. | 2021-08-01 |
| CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients (NCT04990557) | Mahmoud Ramadan mohamed Elkazzaz | 2021-08-01 |
| Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant Therapy (NCT04968002) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-08-01 |
| Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer (NCT05269485) | Anhui Provincial Hospital | 2021-08-01 |
| Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index (NCT05728268) | Shantou Central Hospital | 2021-08-01 |
| Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma (NCT05024266) | First Affiliated Hospital of Zhejiang University | 2021-08-01 |
| LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors (NCT04690699) | Istari Oncology, Inc. | 2021-08-01 |
| Comparing Standard vs. Modified Reconsolidation Blockade for the Treatment of Psychological Trauma (NCT04982211) | Douglas Mental Health University Institute | 2021-08-01 |
| Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia (NCT04566484) | International Vaccine Institute | 2021-08-01 |
| Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis (NCT05001984) | Chang Gung Memorial Hospital | 2021-08-01 |
| Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients (NCT04983121) | Shengjing Hospital | 2021-08-01 |
| Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations (NCT05507606) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-01 |
| Transoral Incisional Fundoplication (TIF) for Patients Suffering From Gastroesophageal Reflux Disease in an Asian Population (NCT07556289) | Chinese University of Hong Kong | 2021-08-01 |
| Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT) (NCT04965831) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-01 |
| Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans (NCT04596644) | New York State Psychiatric Institute | 2021-08-01 |
| Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer (NCT04973904) | Peking Union Medical College Hospital | 2021-08-01 |
| Combined Ketamine and eCBT Intervention for PTSD (NCT04771767) | Queen's University | 2021-08-01 |
| Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score (NCT04989855) | Sun Yat-sen University | 2021-08-01 |
| Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043) (NCT04846634) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-01 |
| PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITIS (NCT04660773) | Alexandria University | 2021-08-01 |
| Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis (NCT04947826) | Shanghai Zhongshan Hospital | 2021-08-01 |
| Schizophrenia Treatment With Photoneuromodulation (NCT05339347) | University of Sao Paulo | 2021-08-01 |
| Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children (NCT05861687) | Finni Kollins | 2021-08-01 |
| Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma (NCT04491370) | New York Medical College | 2021-08-01 |
| Spasmodic Dysphonia Pain (NCT04648891) | Mayo Clinic | 2021-08-01 |
| The Role of Antioxidant Supplementation in Keratoconus Patients (NCT02827747) | University of Miami | 2021-08-01 |
| Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer (NCT04826107) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-01 |
| Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer (NCT05003752) | German Oncology Center, Cyprus | 2021-08-01 |
| The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients (NCT05030623) | Sadat City University | 2021-08-01 |
| Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults (NCT04950751) | Clover Biopharmaceuticals AUS Pty | 2021-08-01 |
| Plant-based Mince vs Beef Mince: Does One Make You Feel Fuller for Longer? (NCT04950595) | Commonwealth Scientific and Industrial Research Organisation, Australia | 2021-08-01 |
| Effects of GRA in Patients With Type 1 (NCT04779645) | University of California, San Diego | 2021-07-31 |
| Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer (NCT04886700) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-07-31 |
| Trial of AD113 and Atomoxetine in OSA Patients With Hypertension (NCT04905979) | Apnimed | 2021-07-31 |
| Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA) (NCT04358471) | Hemera Biosciences | 2021-07-31 |
| Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 (NCT04990544) | Shanghai Zerun Biotechnology Co.,Ltd | 2021-07-31 |
| A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (NCT04939610) | Novartis Pharmaceuticals | 2021-07-30 |
| First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer (NCT04974944) | Sun Yat-Sen University Cancer Center | 2021-07-30 |
| A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML) (NCT04964518) | Ascentage Pharma Group Inc. | 2021-07-30 |
| JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety (NCT04874844) | Beijing Dongfang Biotech Co., Ltd. | 2021-07-30 |
| Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever (NCT04907682) | Bernhard Nocht Institute for Tropical Medicine | 2021-07-30 |
| Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis (NCT04669158) | Stanford University | 2021-07-30 |
| PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS (NCT05279365) | DHR Health Institute for Research and Development | 2021-07-30 |
| Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines. (NCT05027672) | Ministerio de Salud de Ciudad Autónoma de Buenos Aires | 2021-07-30 |
| Adaptive RadioTherapy for OroPharynx Cancer (NCT04901234) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-07-30 |
| A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry) (NCT05039450) | Akero Therapeutics, Inc | 2021-07-30 |
| A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment (NCT04919499) | Boehringer Ingelheim | 2021-07-30 |
| To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis (NCT04684485) | Sun Pharmaceutical Industries Limited | 2021-07-30 |
| A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients (NCT04847583) | Qurient Co., Ltd. | 2021-07-29 |
| Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy (NCT04811716) | Regeneron Pharmaceuticals | 2021-07-29 |
| Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) (NCT04993586) | AnGes, Inc. | 2021-07-29 |
| Local Consolidative Therapy in Colorectal Cancer (NCT05062720) | Fox Chase Cancer Center | 2021-07-29 |
| Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study (NCT04872582) | XIANG YANQUN | 2021-07-29 |
| Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT04883242) | University of Washington | 2021-07-29 |
| MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD (NCT04264026) | VA Loma Linda Health Care System | 2021-07-29 |
| Personalized Immunotherapy in Sepsis (NCT04990232) | Hellenic Institute for the Study of Sepsis | 2021-07-29 |
| SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot (NCT04907214) | Vanderbilt University Medical Center | 2021-07-29 |
| CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old (NCT04269213) | Roswell Park Cancer Institute | 2021-07-29 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM (NCT07217184) | GlaxoSmithKline | 2021-07-29 |
| Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee (NCT04992962) | Pure Green | 2021-07-29 |
| Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection (NCT04742907) | Tsumura USA | 2021-07-29 |
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma (NCT04983407) | Aravive, Inc. | 2021-07-28 |
| Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma (NCT04798781) | Andrew Hendifar, MD | 2021-07-28 |
| A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid Malignancies (NCT04880564) | Curon Biopharmaceutical (Australia) Co Pty Ltd | 2021-07-28 |
| Oxytocin for Weight Loss in Adolescents (NCT04551482) | Massachusetts General Hospital | 2021-07-28 |
| A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma (NCT04814108) | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2021-07-28 |
| A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy (NCT05080959) | Cali Pharmaceuticals LLC | 2021-07-28 |
| Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma (NCT05177237) | Jiangxi Provincial Cancer Hospital | 2021-07-28 |
| Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study） (NCT04992832) | Shanghai East Hospital | 2021-07-28 |
| Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine (NCT04880785) | Fundacion SEIMC-GESIDA | 2021-07-28 |
| A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006) (NCT05013905) | Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2021-07-28 |
| Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer (NCT05016544) | Sun Yat-sen University | 2021-07-28 |
| Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment. (NCT04851535) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2021-07-28 |
| RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy (NCT05044598) | University College, London | 2021-07-28 |
| Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia (NCT04871451) | AEON Biopharma, Inc. | 2021-07-27 |
| An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases (NCT04950114) | Goldfinch Bio, Inc. | 2021-07-27 |
| A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD) (NCT04951076) | Bionomics Limited | 2021-07-27 |
| Atenolol for the Prevention of Osteoporosis (APO) (NCT04905277) | Sundeep Khosla, M.D. | 2021-07-27 |
| Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection (NCT04834908) | Bharat Serums and Vaccines Limited | 2021-07-27 |
| Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients (NCT04923932) | Hutchison Medipharma Limited | 2021-07-27 |
| Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007) (NCT05018416) | Prokidney | 2021-07-27 |
| Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC (NCT04786093) | University of Texas Southwestern Medical Center | 2021-07-27 |
| Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma (NCT05008965) | Oneness Biotech Co., Ltd. | 2021-07-27 |
| Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction (NCT04944706) | Tasly Pharmaceutical Group Co., Ltd | 2021-07-27 |
| Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma (NCT04635189) | University of Rochester | 2021-07-27 |
| Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 (NCT04778059) | US Biotest, Inc. | 2021-07-27 |
| Adriamycin and Ifosfamide Combined With Sintilimab (NCT04589754) | Sun Yat-sen University | 2021-07-26 |
| A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects (NCT04949490) | BioNTech SE | 2021-07-26 |
| ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) (NCT04669587) | EnhancedBio USA Inc. | 2021-07-26 |
| Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML (NCT05048615) | Hospital Universitario Dr. Jose E. Gonzalez | 2021-07-26 |
| A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors (NCT04843709) | Lepu Biopharma Co., Ltd. | 2021-07-26 |
| Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 (NCT04805671) | Invivyd, Inc. | 2021-07-26 |
| Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk (NCT04570956) | Mayo Clinic | 2021-07-26 |
| Vinblastine for Leukoreduction in Newly Diagnosed AML and Hyperleukocytosis (NCT05062278) | Hospital Universitario Dr. Jose E. Gonzalez | 2021-07-26 |
| Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly Population (NCT04983537) | Ministerio de Salud de Ciudad Autónoma de Buenos Aires | 2021-07-26 |
| A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China (NCT05009329) | Allist Pharmaceuticals, Inc. | 2021-07-26 |
| Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis (NCT04846348) | Joseph Butterfield | 2021-07-26 |
| The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus Patients (NCT04811924) | Ciusss de L'Est de l'Île de Montréal | 2021-07-26 |
| A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC (NCT04967625) | Zhejiang Cancer Hospital | 2021-07-26 |